Progenics Pharmaceuticals (PGNX:NASDAQ) Annual Reports & Investor Relations Material

Overview

Progenics Pharmaceuticals is a company focused on providing medical solutions for patients with serious ailments. They are involved in the development and commercialization of therapeutic products that can be used to address a variety of medical challenges. Working both in the United States and abroad, Progenics Pharmaceuticals aims to fill the gaps left by current treatments, providing hope to those who might otherwise suffer without effective options.

Frequently Asked Questions

What is Progenics Pharmaceuticals's ticker?

Progenics Pharmaceuticals's ticker is PGNX

What exchange is Progenics Pharmaceuticals traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Progenics Pharmaceuticals's headquarters?

They are based in Tarrytown, New York

How many employees does Progenics Pharmaceuticals have?

There are 51-200 employees working at Progenics Pharmaceuticals

What is Progenics Pharmaceuticals's website?

It is http://www.progenics.com

What type of sector is Progenics Pharmaceuticals?

Progenics Pharmaceuticals is in the Healthcare sector

What type of industry is Progenics Pharmaceuticals?

Progenics Pharmaceuticals is in the Drug Manufacturers - Major industry

Who are Progenics Pharmaceuticals's peers and competitors?

The following five companies are Progenics Pharmaceuticals's industry peers:

- Johnson & Johnson

- Novartis AG

- Rigel Pharmaceuticals

- Sanofi

- Bayer AG